Skip to results
Modify your search
NARROW
1-6 of 6
Authors: Camilla Muccini
Journal Article
In-depth Analysis of the HIV Reservoir Confirms Effectiveness and Safety of Dolutegravir/Lamivudine in a Phase 4 Randomized Controlled Switch Trial (RUMBA)
The Journal of Infectious Diseases, Volume 231, Issue 1, 15 January 2025, Pages e91–e100, https://doi.org/10.1093/infdis/jiae405
Published: 03 September 2024
Journal Article
One Year of Long-Acting Cabotegravir and Rilpivirine in People With Human Immunodeficiency Virus and Long Exposure to Antiretroviral Therapy: Data From the SCohoLART Study
Open Forum Infectious Diseases, Volume 11, Issue 7, July 2024, ofae326, https://doi.org/10.1093/ofid/ofae326
Published: 20 June 2024
Journal Article
Reply
The Journal of Infectious Diseases, Volume 225, Issue 11, 1 June 2022, Pages 2050–2051, https://doi.org/10.1093/infdis/jiac070
Published: 26 February 2022
Journal Article
Integrase Strand Transfer Inhibitor Use and Cancer Incidence in a Large Cohort Setting
Open Forum Infectious Diseases, Volume 9, Issue 3, March 2022, ofac029, https://doi.org/10.1093/ofid/ofac029
Published: 19 January 2022
Journal Article
Candidemia in Coronavirus Disease 2019 (COVID-19) Patients: Incidence and Characteristics in a Prospective Cohort Compared With Historical Non–COVID-19 Controls
Clinical Infectious Diseases, Volume 73, Issue 9, 1 November 2021, Pages e2838–e2839, https://doi.org/10.1093/cid/ciaa1594
Published: 30 October 2020
Journal Article
Central Nervous System Safety During Brief Analytic Treatment Interruption of Antiretroviral Therapy Within 4 Human Immunodeficiency Virus Remission Trials: An Observational Study in Acutely Treated People Living With Human Immunodeficiency Virus
Clinical Infectious Diseases, Volume 73, Issue 7, 1 October 2021, Pages e1885–e1892, https://doi.org/10.1093/cid/ciaa1344
Published: 11 September 2020
